Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of...
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2021 |
Language: | English |
Physical Description: | 1 electronic resource (240 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545142804498 |
---|---|
ctrlnum |
(CKB)5400000000040638 (oapen)https://directory.doabooks.org/handle/20.500.12854/68385 (EXLCZ)995400000000040638 |
collection |
bib_alma |
record_format |
marc |
spelling |
Ecke, Thorsten edt Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 1 electronic resource (240 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer. English Medicine bicssc Metallothionein urothelium urothelial cancer cadmium exposure zinc transporter bladder TAGLN F-actin PTEN p53 tumorigenesis proliferation invasion TERT promoter mutations FGFR3 non muscle invasive bladder cancer BCG therapy bladder cancer JAK-STAT pathway combination therapy oncolytic adenovirus virotherapy STAT3/5 inhibitor JAK inhibitor XVir-N-31 bladder cancer detection urinary biomarkers DNA methylation ECRG4 ITIH5 biomarker cancer grade metabolomics MS NMR biomarkers tumor markers prognosis heparanase syndecan-1 heparan sulfate proteoglycans (HSPGs) urothelial carcinoma miRNA quantitative PCR tumor marker voided urine cytology KDM7A histone demethylase TC-E 5002 androgen receptor drug resistance non-invasive detection telomerase somatic mutations TERT promoter region muscle-invasive bladder cancer chemotherapy immunotherapy personalized medicine predictive biomarker survivin BIRC5 macrophage KRT20 ERBB2 MIBC prediction RT-qPCR adjuvant chemotherapy survival 3-03943-685-6 3-03943-686-4 Otto, Thomas edt Ecke, Thorsten oth Otto, Thomas oth |
language |
English |
format |
eBook |
author2 |
Otto, Thomas Ecke, Thorsten Otto, Thomas |
author_facet |
Otto, Thomas Ecke, Thorsten Otto, Thomas |
author2_variant |
t e te t o to |
author2_role |
HerausgeberIn Sonstige Sonstige |
title |
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
spellingShingle |
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
title_full |
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
title_fullStr |
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
title_full_unstemmed |
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
title_auth |
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
title_new |
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
title_sort |
diagnostic, prognostic and predictive biological markers in bladder cancer - illumination of a vision 2.0 |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2021 |
physical |
1 electronic resource (240 p.) |
isbn |
3-03943-685-6 3-03943-686-4 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT eckethorsten diagnosticprognosticandpredictivebiologicalmarkersinbladdercancerilluminationofavision20 AT ottothomas diagnosticprognosticandpredictivebiologicalmarkersinbladdercancerilluminationofavision20 |
status_str |
n |
ids_txt_mv |
(CKB)5400000000040638 (oapen)https://directory.doabooks.org/handle/20.500.12854/68385 (EXLCZ)995400000000040638 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1796651990681387009 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04486nam-a2201165z--4500</leader><controlfield tag="001">993545142804498</controlfield><controlfield tag="005">20231214133100.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040638</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68385</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040638</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ecke, Thorsten</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (240 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Metallothionein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urothelium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urothelial cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cadmium exposure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">zinc transporter</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bladder</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TAGLN</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">F-actin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PTEN</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">p53</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumorigenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proliferation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">invasion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TERT promoter mutations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FGFR3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non muscle invasive bladder cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BCG therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bladder cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">JAK-STAT pathway</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">combination therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oncolytic adenovirus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">virotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STAT3/5 inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">JAK inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">XVir-N-31</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bladder cancer detection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urinary biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DNA methylation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ECRG4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ITIH5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">grade</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metabolomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NMR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor markers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparanase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">syndecan-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparan sulfate proteoglycans (HSPGs)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urothelial carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">miRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quantitative PCR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor marker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">voided urine cytology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">KDM7A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">histone demethylase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TC-E 5002</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">androgen receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-invasive detection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">telomerase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">somatic mutations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TERT promoter region</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">muscle-invasive bladder cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">predictive biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">survivin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BIRC5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">macrophage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">KRT20</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ERBB2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MIBC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prediction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RT-qPCR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adjuvant chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">survival</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-685-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-686-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Otto, Thomas</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ecke, Thorsten</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Otto, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:42:22 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337915360004498&Force_direct=true</subfield><subfield code="Z">5337915360004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337915360004498</subfield></datafield></record></collection> |